FDA
approval
· 2018-04-30
FDA Approved: BUMETANIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
Summary
FDA approved Bumetanide as a generic via Original Application (ANDA 202900), confirming bioequivalence to the reference product. It is indicated for edema assoc…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BUMETANIDE (BUMETANIDE)